Insider Transactions in Q1 2024 at Adma Biologics, Inc. (ADMA)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 31
2024
|
Adam S Grossman President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
21,752
-0.81%
|
$130,512
$6.6 P/Share
|
|
Mar 31
2024
|
Kaitlin M. Kestenberg Messina COO and SVP, Compliance |
SELL
Payment of exercise price or tax liability
|
Direct |
2,085
-1.82%
|
$12,510
$6.6 P/Share
|
|
Mar 19
2024
|
Steve Elms |
SELL
Open market or private sale
|
Indirect |
411,829
-16.29%
|
$2,470,974
$6.08 P/Share
|
|
Mar 18
2024
|
Steve Elms |
SELL
Open market or private sale
|
Indirect |
49,887
-1.94%
|
$299,322
$6.01 P/Share
|
|
Mar 15
2024
|
Steve Elms |
SELL
Open market or private sale
|
Indirect |
183,008
-6.63%
|
$1,098,048
$6.01 P/Share
|
|
Mar 14
2024
|
Steve Elms |
SELL
Open market or private sale
|
Indirect |
448,276
-13.97%
|
$2,689,656
$6.05 P/Share
|
|
Mar 13
2024
|
Steve Elms |
SELL
Open market or private sale
|
Indirect |
407,000
-11.26%
|
$2,442,000
$6.21 P/Share
|
|
Mar 07
2024
|
Adam S Grossman President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
28,763
-1.06%
|
$172,578
$6.16 P/Share
|
|
Mar 07
2024
|
Brian Lenz EVP, CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
16,965
-2.36%
|
$101,790
$6.16 P/Share
|
|
Mar 06
2024
|
Adam S Grossman President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
55,003
-2.0%
|
$330,018
$6.12 P/Share
|
|
Mar 06
2024
|
Brian Lenz EVP, CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
16,677
-2.26%
|
$100,062
$6.12 P/Share
|
|
Feb 29
2024
|
Brian Lenz EVP, CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,935
-0.67%
|
$24,675
$5.36 P/Share
|
|
Feb 29
2024
|
Adam S Grossman President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
9,588
-0.35%
|
$47,940
$5.36 P/Share
|
|
Feb 26
2024
|
Steve Elms |
BUY
Grant, award, or other acquisition
|
Direct |
24,040
+23.92%
|
-
|
|
Feb 26
2024
|
Bryant Fong |
BUY
Grant, award, or other acquisition
|
Direct |
24,040
+22.26%
|
-
|
|
Feb 26
2024
|
Lawrence P. Guiheen |
BUY
Grant, award, or other acquisition
|
Direct |
24,040
+13.51%
|
-
|
|
Feb 26
2024
|
Young Kwon |
BUY
Grant, award, or other acquisition
|
Direct |
24,040
+7.39%
|
-
|
|
Feb 26
2024
|
Jerrold B Grossman |
BUY
Grant, award, or other acquisition
|
Direct |
24,040
+4.89%
|
-
|
|
Feb 26
2024
|
Adam S Grossman President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
557,728
+16.78%
|
-
|
|
Feb 26
2024
|
Alison Cecily Finger |
BUY
Grant, award, or other acquisition
|
Direct |
24,040
+50.0%
|
-
|
|
Feb 25
2024
|
Adam S Grossman President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
22,457
-1.01%
|
$112,285
$5.26 P/Share
|
|
Feb 25
2024
|
Brian Lenz EVP, CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
8,257
-1.1%
|
$41,285
$5.26 P/Share
|